propranolol has been researched along with Diabetic Retinopathy in 4 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effect of propranolol on retinal neovascularization due to proliferative diabetic retinopathy (PDR)." | 7.88 | Propranolol for Proliferative Diabetic Retinopathy. ( Domalpally, A; Hendrick, AM; Ip, MS; Kulkarni, AD; Lavine, JA, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hendrick, AM | 1 |
| Lavine, JA | 1 |
| Domalpally, A | 1 |
| Kulkarni, AD | 1 |
| Ip, MS | 1 |
| Zheng, Z | 1 |
| Chen, H | 1 |
| Xu, X | 1 |
| Li, C | 1 |
| Gu, Q | 1 |
| Bariciak, MD | 1 |
| Nichols, BD | 1 |
| Lundbaek, K | 1 |
1 review available for propranolol and Diabetic Retinopathy
| Article | Year |
|---|---|
Cataracts in systemic diseases and syndromes.
Topics: Amiodarone; Cataract; Cataract Extraction; Diabetes Complications; Diabetic Retinopathy; Female; Hum | 1995 |
3 other studies available for propranolol and Diabetic Retinopathy
| Article | Year |
|---|---|
Propranolol for Proliferative Diabetic Retinopathy.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Diabetic Retinopa | 2018 |
Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Basement Membrane; B | 2007 |
Growth hormoe and diabetic angiopathy.
Topics: Adolescent; Blood Glucose; Capillary Permeability; Child; Diabetes Mellitus; Diabetes Mellitus, Type | 1973 |